{"id":"W2133329597","doi":"10.1016/s1474-4422(13)70308-9","title":"Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":570,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Toronto","funders":"Serono Symposia International Foundation; Universitätsspital Basel; Universität Basel","keywords":"Teriflunomide; Double blind; Multiple sclerosis; Medicine; Placebo; Internal medicine; Physical therapy; Alternative medicine; Psychiatry; Pathology; Fingolimod","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001612787,0.0003426069,0.001556665,0.0001416645,0.0003781144,0.00005630185,0.0003510821,0.0001447856,0.00005382131],"category_scores_gemma":[0.002607235,0.0001915845,0.0002620372,0.0001649046,0.000377942,0.00009324794,0.0001365877,0.0005252814,0.00002220065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003276572,"about_ca_system_score_gemma":0.00006691301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004284255,"about_ca_topic_score_gemma":0.00007487942,"domain_scores_codex":[0.9970651,0.0005126095,0.0005528447,0.0005636798,0.0004144628,0.0008913557],"domain_scores_gemma":[0.9954425,0.003090634,0.0002821319,0.0007595356,0.0002490601,0.0001761972],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9836249,0.0006745658,0.004339986,0.00003719278,0.0003033448,0.000002839966,0.0001506649,0.00003632573,0.001462731,0.00002482372,0.003574903,0.005767752],"study_design_scores_gemma":[0.9724107,0.008721737,0.003082932,0.00004098257,0.0002887715,0.000005020403,0.000009005554,0.00393692,0.0001889572,0.00002701406,0.01110342,0.0001844865],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787464,0.00005811303,0.0008701081,0.007686846,0.0005364057,0.01125078,0.00004010116,0.0001234328,0.0006878383],"genre_scores_gemma":[0.9923029,0.00008386208,0.000618425,0.002414422,0.001383243,0.002911747,0.0000572947,0.00006560121,0.0001624941],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01355654,"threshold_uncertainty_score":0.7812588,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1090696516901444,"score_gpt":0.3401949859973124,"score_spread":0.231125334307168,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}